Home Newsfeeds Traders Circulate FDA Approval/Tentative Approval For TG Therapeutics ORIG-1

Traders Circulate FDA Approval/Tentative Approval For TG Therapeutics ORIG-1

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761238

byBenzinga Newsdesk

December 28, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761238

Lilium Stock Is Taking Off Thursday: What’s Happening?

By Adam Eckert

December 7, 11:09 AM

Shares of electric Vertical Take-Off and Landing (eVTOL) company Lilium N.V. (NASDAQ: LILM) are trading higher Thursday after the company announced it signed a Memorandum of Understanding (MoU) with Lufthansa Group

LILM

Incyte Announces New Long-Term Data From Phase 3 TRuE-V Program Demonstrates Efficacy Of Continued Treatment With Opzelura Cream In Nonsegmental Vitiligo Patients

By Benzinga Newsdesk

October 11, 10:32 AM

- Patients who initially experienced limited or no facial or total body repigmentation at six months achieved improved repigmentation after continued treatment with Opzelura for up to two years- Results were presented in

INCY

Elon Musk Says Tesla Cybertruck Could Be Better At This Than Model Y

By Shanthi Rexaline

March 29, 2:57 AM

More details have emerged on Tesla Inc.'s (NASDAQ: TSLA) highly anticipated Cybertruck, set for release in 2023.

Progressive Reports January 2024 Results; EPS $1.18; Net Income Of $700.7M

By Benzinga Newsdesk

February 14, 9:21 AM

The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended January 31, 2024: January (millions, except per share amounts and ratios; unaudited)2024Net premiums

PGR

Traders Circulate FDA Approval/Tentative Approval For TG Therapeutics ORIG-1

Related Posts

Lilium Stock Is Taking Off Thursday: What’s Happening?

Incyte Announces New Long-Term Data From Phase 3 TRuE-V Program Demonstrates Efficacy Of Continued Treatment With Opzelura Cream In Nonsegmental Vitiligo Patients

Elon Musk Says Tesla Cybertruck Could Be Better At This Than Model Y

Progressive Reports January 2024 Results; EPS $1.18; Net Income Of $700.7M